News
Eli Lilly partners with Hong Kong-based Insilico Medicine on a $2.75 billion AI-driven drug discovery deal for exclusive global rights to preclinical oral therapies in metabolic indications.
Read more...Piramal Pharma Solutions' Grangemouth UK Facility Achieves Milestone with 1,500th ADC Batch Delivery
6 April 2026
Piramal Pharma Solutions announces the successful delivery of its 1,500th antibody-drug conjugate batch from its Grangemouth, UK facility, highlighting its prowess in contract manufacturing.
Read more...3 April 2026
Chinese innovative drug out-licensing deals surged 132% year-over-year to $56.7 billion across 44 transactions since the start of 2026, underscoring the sector's emergence as the world's second-largest biopharma development hub.
Read more...Chinese innovative drug out-licensing deals reached $56.7 billion across 44 transactions since early 2026, up 132% year-over-year, as the sector gains pillar industry status.
Read more...1 April 2026
The European Parliament has approved a negotiating mandate for the Critical Medicines Act, emphasizing local production requirements and joint procurement to enhance medicine supply security across the EU.
Read more...31 March 2026
The 17th Asia Pharma Expo 2026 began on March 29 in Dhaka, featuring over 400 exhibitors from 20+ countries displaying innovations in pharmaceutical processing, packaging, APIs, cleanroom systems, and laboratory instruments.
Read more...EMA's CHMP recommended five new medicines for approval, including conditional authorisation for Adstiladrin and Imdylltra for unmet needs in bladder cancer and lung cancer.[1]
Read more...30 March 2026
The 2026 Asia Pharma Expo kicked off in Bangladesh, bringing together over 400 exhibitors from more than 20 countries to showcase advancements in pharmaceutical manufacturing, equipment, and contract services.
Read more...30 March 2026
The EMA Management Board adopted the 2025 annual report, highlighting 104 new medicine recommendations, and confirmed governance for implementing new EU pharmaceutical legislation impacting regulatory compliance and operations.
Read more...Zimmer Biomet received three awards at the Healthcare Asia Medtech Awards 2026 in Singapore, recognizing breakthroughs in infection prevention, AI-driven recovery solutions, and surgeon engagement across the Asia Pacific region.[1]
Read more...